Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Ropivacaine
Product Details | |
---|---|
Synonyms | (S)-Ropivacaine; (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide |
Product Type | Chemical |
Properties | |
Formula | C17H26N2O |
MW | 274.4 |
CAS | 84057-95-4 |
Source/Host Chemicals | Synthetic |
Purity Chemicals | ≥98% (HPLC) |
Appearance | White to off-white powder. |
Solubility | Soluble in chloroform or acentonitrile. Slightly soluble in DMSO or methanol. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by Chemodex. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | ZKMNUMMKYBVTFN-UHFFFAOYSA-N |
Smiles | CC1=CC=CC(C)=C1NC(C2CCCCN2CCC)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | -20°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Ropivacaine is a long-acting amide local anaesthetic agent. Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. It is a pure S(-)enantiomer and less lipophilic than racemic sodium channel blockers, such as bupivacaine and is less likely to penetrate large myelinated motor fibres, resulting in a relatively reduced motor blockade. Thus, ropivacaine has a greater degree of motor sensory differentiation, which could be useful when motor blockade is undesirable. The reduced lipophilicity is also associated with decreased potential for central nervous system toxicity and cardiotoxicity.
(1) R.D. Wang, et al.; Exp. Opin. Pharmacother. 2, 2051 (2001) (Review) | (2) T.G. Hansen; Exp. Rev. Neurother. 4, 781 (2004) (Review) | (3) G. Kuthiala & G. Chaudhary; Indian J. Anaesth. 55, 104 (2011) (Review)